480 related articles for article (PubMed ID: 17573397)
1. Neuromuscular junction in health and disease.
Hirsch NP
Br J Anaesth; 2007 Jul; 99(1):132-8. PubMed ID: 17573397
[TBL] [Abstract][Full Text] [Related]
2. [The perioperative management of myasthenia gravis patients].
Kristensen ML; Gätke MR
Ugeskr Laeger; 2013 Nov; 175(48A):. PubMed ID: 25353189
[TBL] [Abstract][Full Text] [Related]
3. [The perioperative management of myasthenia gravis patients].
Kristensen ML; Gätke MR
Ugeskr Laeger; 2014 Oct; 176(44):. PubMed ID: 25354000
[TBL] [Abstract][Full Text] [Related]
4. Perianesthetic Implications and Considerations for Myasthenia Gravis.
Muckler VC; O'Brien JM; Matson SE; Rice AN
J Perianesth Nurs; 2019 Feb; 34(1):4-15. PubMed ID: 29980408
[TBL] [Abstract][Full Text] [Related]
5. [Severity of myasthenia gravis is related to the degree of neuromuscular blocking effect by isoflurane].
Kadosaki M; Enzan K; Horiguchi T; Komatsu H; Suzuki M
Masui; 1993 Jun; 42(6):906-9. PubMed ID: 8320811
[TBL] [Abstract][Full Text] [Related]
6. Myasthenia gravis in children and its anaesthetic implications.
Brown TC; Gebert R; Meretoja OA; Shield LK
Anaesth Intensive Care; 1990 Nov; 18(4):466-72. PubMed ID: 2268010
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological analysis of neuromuscular synaptic function in myasthenia gravis patients and animal models.
Plomp JJ; Morsch M; Phillips WD; Verschuuren JJ
Exp Neurol; 2015 Aug; 270():41-54. PubMed ID: 25620417
[TBL] [Abstract][Full Text] [Related]
8. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
9. Anesthesia and myasthenia gravis.
Blichfeldt-Lauridsen L; Hansen BD
Acta Anaesthesiol Scand; 2012 Jan; 56(1):17-22. PubMed ID: 22091897
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of neuromuscular blocking agents: is the increased understanding of importance to the practising anaesthetist?
Aglan MY; Pollard BJ
Pharmacol Ther; 1995; 68(3):365-83. PubMed ID: 8788563
[TBL] [Abstract][Full Text] [Related]
11. [Neuromuscular junction: pharmacology, toxicology and clinical use of neuromuscular blocking agents].
Conte-Camerino D; Siro-Brigiani G
Clin Ter; 1975 Mar; 72(5):461-91. PubMed ID: 773593
[No Abstract] [Full Text] [Related]
12. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.
Murray MJ; DeBlock H; Erstad B; Gray A; Jacobi J; Jordan C; McGee W; McManus C; Meade M; Nix S; Patterson A; Sands MK; Pino R; Tescher A; Arbour R; Rochwerg B; Murray CF; Mehta S
Crit Care Med; 2016 Nov; 44(11):2079-2103. PubMed ID: 27755068
[TBL] [Abstract][Full Text] [Related]
13. [Neurophysiological studies of the neuromuscular junction].
González-Hidalgo M
Rev Neurol; 2005 Aug 1-15; 41(3):163-76. PubMed ID: 16047301
[TBL] [Abstract][Full Text] [Related]
14. Myasthenia gravis and other neuromuscular junction disorders.
Jacob S; Viegas S; Lashley D; Hilton-Jones D
Pract Neurol; 2009 Dec; 9(6):364-71. PubMed ID: 19923120
[No Abstract] [Full Text] [Related]
15. [Perioperative management of patients with neuromuscular disorders].
Johannsen S; Kranke P; Reiners K; Schuster F
Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Nov; 44(11-12):748-55; quiz 756. PubMed ID: 19918707
[TBL] [Abstract][Full Text] [Related]
16. [Neurophysiologic assessment of disorders affecting the neuromuscular junction].
Kuwabara S
Brain Nerve; 2011 Jul; 63(7):713-7. PubMed ID: 21747141
[TBL] [Abstract][Full Text] [Related]
17. Neuromuscular interaction of sevoflurane--cisatracurium in a myasthenic patient.
Baraka AS; Taha SK; Kawkabani NI
Can J Anaesth; 2000 Jun; 47(6):562-5. PubMed ID: 10875720
[TBL] [Abstract][Full Text] [Related]
18. [Electrodiagnosis in disorders of neuromuscular transmission].
Chumillas MJ; Cortés V
Rev Neurol; 2000 Jan 1-15; 30(1):65-70. PubMed ID: 10743000
[TBL] [Abstract][Full Text] [Related]
19. Modeling the neuromuscular junction in vitro: an approach to study neuromuscular junction disorders.
Castellanos-Montiel MJ; Velasco I; Escobedo-Avila I
Ann N Y Acad Sci; 2021 Mar; 1488(1):3-15. PubMed ID: 33040338
[TBL] [Abstract][Full Text] [Related]
20. Anesthesia issues in the perioperative management of myasthenia gravis.
Dillon FX
Semin Neurol; 2004 Mar; 24(1):83-94. PubMed ID: 15229795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
